The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Weil, Gotshal & Manges LLP

201 REDWOOD SHORES PARKWAY, REDWOOD SHORES, CA 94065, USA
Tel:
Work +1 650 802 3000
Fax:
Fax +1 650 802 3100
Email:
Web:
www.weil.com

Karen Ballack

Tel:
Work +1 650 802 3120
Email:
Weil, Gotshal & Manges LLP

Career

Karen N Ballack, a partner in Weil’s Silicon Valley office, has extensive experience in technology and intellectual property alliances and transactions. She works with a range of technology companies, particularly in the semiconductor, computer, internet, biotechnology, medical device and pharmaceutical industries. She is regularly engaged to work on complex and sophisticated technology and intellectual property transactions. Representative matters include licensing, R&D collaborations, strategic alliances, joint ventures, intellectual property acquisitions and divestitures, cloud computing arrangements, outsourcing transactions, and manufacture, supply and distribution arrangements.

Education

San Diego State University (BS, summa cum laude, 1981); University of San Francisco (JD, 1986).


United States: Intellectual property

Patents: licensing

Within: Patents: licensing

Weil, Gotshal & Manges LLP’s key area of expertise is technology transactions, but the team is also adept at assisting life sciences clients. On the corporate transactional side, the group covers licences in relation to mergers and acquisitions, joint ventures, and strategic alliances, while the non-transactional practice includes research and development agreements as well as e-commerce contracts, outsourcing transactions and professional service agreements. The firm is present in New York, where practice head Michael Epstein, Jeffrey Osterman and Charan Sandhu are based, and on the West Coast; here Karen Ballack is the main contact in Silicon Valley after John Brockland left for Hogan Lovells US LLP. Despite Brockland’s departure the group handles a large number of high-profile matters, such as advising Sanofi on the licensing aspects of its $25bn agreement with Boehringer Ingelheim through which the client swapped its animal health business Merial for Boehringer’s consumer healthcare business. General Electric, Signet Jewelers and Eli Lilly are other key clients.

[back to top]

United States: Media, technology and telecoms

Technology: transactions

Within: Technology: transactions

Weil, Gotshal & Manges LLP is regularly engaged in sophisticated transactions, including technology acquisitions and dispositions, joint ventures and strategic alliances, as well as research and development (R&D) collaborations, licensing agreements, outsourcing transactions and e-commerce agreements. New York-based global technology and IP transactions head Michael Epstein acted for inVentiv Health in the technology and IP aspects of its $4.6bn merger with INC Research Holdings; Charan Sandhu advised the transaction committee of the board of directors of Reynolds American (Reynolds) on the technology and IP aspects of its $60.6bn sale to British American Tobacco (BAT) of the 57.8% of Reynolds’ stock that BAT did not already own; and Jeffrey Osterman advised French multinational pharmaceutical company Sanofi on the technology and IP aspects of the $25bn exchange of its animal health business for the consumer healthcare business of Boehringer Ingelheim. Silicon Valley-based Karen Ballack is also highly rated. Richard Climan, John Brockland, Max Scott, Keith Flaum, Jane Ross, and Christopher Moore joined Hogan Lovells US LLP.

[back to top]


Back to index

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to